Keyphrases
Inflammatory Bowel Disease
100%
Breast Milk
100%
Infliximab
100%
Nursing Mothers
100%
Breast
18%
Nursing
18%
Infliximab Levels
18%
Crohn's Disease
9%
Neonate
9%
Immune Suppression
9%
Toleration
9%
Partum
9%
Group of Eight
9%
Intestine
9%
ELISA Assay
9%
Systemic Immune Response
9%
Maternal Serum
9%
Lactating Women
9%
Local Effects
9%
Healthy Mothers
9%
IBD Patients
9%
Immune Sensitization
9%
Reinitiation
9%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Human Milk
100%
Infliximab
100%
Infusion
16%
Breast Feeding
16%
Epileptic Absence
8%
Enzyme Linked Immunosorbent Assay
8%
Immunosuppressive Treatment
8%
Neonate
8%
Sensitization
8%
Intestine
8%
Patient with Crohn's Disease
8%
Maternal Serum
8%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Infliximab
100%
Crohn's Disease
8%
Sensitization
8%
ELISA
8%
Intestine
8%
Maternal Serum
8%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Infliximab
100%
Epileptic Absence
8%
Crohn's Disease
8%
Enzyme-Linked Immunosorbent Assay
8%
Food Science
Feeding Behavior
100%
Enzyme-Linked Immunosorbent Assay
50%